A new study has found that a group of diabetes drugs called SGLT2 inhibitors may increase the risk of a rare but dangerous ...

Researchers at Thomas Jefferson University have found a new way to help. Their study showed that using two diabetes ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Treating and managing type 2 diabetes successfully can require a team. Learn from these specialists how to hit your health ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

Type 2 diabetes can increase your risk of pancreatic cancer, but the amount of time since your diagnosis can affect your risk ...

From the health benefits to side effects, here's what to know about the popular new GLP-1 weight loss medications.

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...